CIBMTR Reporting Implementation Guide
0.1.6 - Trial Use 1
CIBMTR Reporting Implementation Guide
0.1.6 - Trial Use 1
This page is part of the CIBMTR Reporting Implementation Guide (v0.1.6: Release Draft) based on FHIR R4. This is the current published version. For a full list of available versions, see the Directory of published versions 
Generated Narrative: MedicationAdministration
Resource MedicationAdministration "MedicationAdministration-Example2"
Profile: CIBMTR Medication Administration (mcode)
Security Labels: http://terminology.cibmtr.org/codesystem/transplant-center
status: completed
medication: ETOPOSIDE 20 MG/ML IV SOLN (RxNorm#4179 "etoposide"; RxNorm#310248 "etoposide 20 MG/ML Injectable Solution"; RxNorm#362972 "etoposide Injectable Solution [Vepesid]"; RxNorm#206832 "etoposide 20 MG/ML Injectable Solution [Vepesid]")
subject: Patient/PatientExample6 ""
effective: 2020-07-22 16:58:05+0000
reasonCode: Cancer (CMS/HCC) (SNOMED CT#363346000 "Malignant neoplastic disease (disorder)"; International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM)#C80.1 "Malignant (primary) neoplasm, unspecified")
request: MedicationRequest/MedicationRequest-Etoposide-Example
| - | Route | Method | Dose |
| * | Intravenous route (SNOMED CT#47625008) | Inject - dosing instruction imperative (qualifier value) (SNOMED CT#422145002) | 73 milligram (Details: UCUM code mg = 'mg') |